Viewing Study NCT06324357

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 7:08 PM

Ignite Modification Date: 2026-01-01 @ 7:11 PM

Study NCT ID: NCT06324357

Status: RECRUITING

Last Update Posted: 2025-12-22

First Post: 2024-03-15

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Sponsor: Boehringer Ingelheim

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module